Fate Therapeutics, Inc. (NASDAQ:FATE) Shares Sold by Prudential Financial Inc.

Prudential Financial Inc. trimmed its position in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 9.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 321,401 shares of the biopharmaceutical company’s stock after selling 35,200 shares during the […]